Kalera Public Limited (KAL)
NASDAQ: KAL
· Real-Time Price · USD
1.12
0.00 (0.00%)
At close: Apr 14, 2023, 10:00 PM
Company Description
Kalera Public Limited Company, together with its subsidiaries, operates as a hydroponic vertical farming company in the United States and internationally.
The company operates vertical hydroponic farms and related technology development facilities that produce various lettuce and microgreens for the retail and food service markets.
It also holds a license to patented technology related to geopolymer concrete.
Kalera Public Limited Company is headquartered in Orlando, Florida.
Kalera Public Limited

Country | United States |
IPO Date | Jun 29, 2022 |
Industry | Agricultural Farm Products |
Sector | Consumer Defensive |
Employees | 438 |
CEO | Fernando Cornejo |
Contact Details
Address: 7455 Emerald Dunes Drive Orlando, Florida United States | |
Website | https://kalera.com |
Stock Details
Ticker Symbol | KAL |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001909152 |
CUSIP Number | G52251108 |
ISIN Number | n/a |
Employer ID | 00-0000000 |
SIC Code | 0100 |
Key Executives
Name | Position |
---|---|
James B. Leighton M.B.A. | Chief Executive Officer, Pres & Director |
Aric D. Nissen M.B.A. | Chief Marketing Officer |
Austin Martin M.B.A. | Chief Operating Officer |
Fernando Cornejo M.B.A. | Chief Financial Officer |
Dr. Cristian Eugen Toma Ph.D. | Co-Founder, Chief Science Officer & Director |
Dr. Henner Schwarz | Managing Director of EMEA & Asia |
Dr. Jade Stinson M.B.A., Ph.D. | Co-founder & Pres of Vindara Inc. |
Heiko Hosse | Senior Vice President of Design & Engineering |
Jan-Gerd Frerichs | Senior Vice President of Software |
Mark Shapiro | Chief Restructuring Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 26, 2023 | 8-K | Current Report |
May 11, 2023 | 8-K | Current Report |
May 02, 2023 | 25-NSE | Filing |
May 01, 2023 | 8-K | Current Report |
Apr 10, 2023 | 8-K | Current Report |
Apr 04, 2023 | 8-K | Current Report |
Feb 08, 2023 | SC 13D | Filing |
Feb 07, 2023 | 4 | Filing |
Jan 26, 2023 | 8-K | Current Report |
Jan 05, 2023 | 8-K | Current Report |